Belén Garijo: Sparking Discovery, Elevating Humanity

Belén Garijo shared a post on LinkedIn:

“Last year, at our 2023 Capital Markets Day, we committed to return to growth in 2024. Today, at our 2024 CMD, we had proudly confirmed that we are well on track to deliver on this goal and to continue delivering sustainable growth in the years to come.

Merck’s financial strength showed our consistent ability to grow profits at a faster rate than sales, and Earnings Per Share (EPS), even faster than profits. Our historical ability to consistently increase profit margins over time contributes to compounded value for our stakeholders.

Across Life Science, Healthcare, and Electronics, we are strongly positioned to leverage attractive market tailwinds and global megatrends. Guided by our vision of “Sparking Discovery, Elevating Humanity,” our high performing global teams will deliver sustainable growth and create positive impact for patients, customers, and society as a whole.

To everyone who joined us today, a big thanks for your interest and ongoing support.”

Belén Garijo is the Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. She joined the company in 2011 as Chief Operating Officer of the Biopharma business, becoming President and CEO of Healthcare in 2015. In July 2020, Belén Garijo was appointed Vice Chairman of the Executive Board and Deputy CEO in addition to her role as CEO of the Healthcare business. She moved from Deputy CEO to CEO in May 2021. Under her leadership, Healthcare at Merck KGaA, Darmstadt, Germany, has become a key player in the area of oncology, immunology and immuno-oncology, after the profound repositioning of the portfolio, the reorganization of R&D and the transformation of the commercial model.

Before joining Merck, Belén Garijo served as the Senior Vice President of Global Operations Europe at Sanofi-Aventis and Global Integration Leader of Genzyme after its acquisition by Sanofi. She previously held several local and global executive positions, both in R&D and commercial, at various companies at the forefront of the Healthcare sector. She started her career as a practicing physician at La Paz hospital in Madrid before moving to the pharmaceutical industry. She is a medical doctor, specialized in clinical pharmacology.